Severe inflammation has been shown to induce a shedding of the endothelial glycocalyx (EGX). Inflammatory cytokines, such as tumor necrosis factor α (TNF-α), impede the thickness of the EGX. While a controlled inflammatory reaction occurs already in normal pregnancy, women with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome had an exaggerated inflammatory response. This study investigates the shedding of the glycocalyx during normal pregnancy and in women with HELLP syndrome. Glycocalyx components (syndecan 1, heparan sulfate, and hyaluronic acid) were measured in serum of healthy women throughout pregnancy (4 time points, n = 26), in women with HELLP syndrome (n = 17) before delivery and in nonpregnant volunteers (n = 10). Serum concentrations of TNF-α and soluble TNF-α receptors (sTNF-Rs) were assessed once in all 3 groups. Syndecan 1 serum concentrations constantly rose throughout normal pregnancy. Immediately before delivery, a 159-fold increase was measured compared to nonpregnant controls (P < .01). Even higher amounts were observed in patients with HELLP prior to delivery (median 12 252 ng/mL) compared to healthy women matched by gestational age (median 5943 ng/mL; P < .01). Relevantly, increased serum levels of heparan sulfate, hyaluronic acid, and sTNF-Rs were only detected in patients with HELLP (P < .01). These findings suggest that considerable amounts of syndecan 1 are released into maternal blood during uncomplicated pregnancy. The HELLP syndrome is associated with an even more pronounced shedding of glycocalyx components. The maternal vasculature as well as the placenta has to be discussed as a possible origin of circulating glycocalyx components.
KleinNJShennanGIHeydermanRSLevinM. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992;102(pt 4):821–832.
6.
JacobMBrueggerDRehmMThe endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007;73(3):575–586.
7.
RehmMZahlerSLotschMEndothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100(5):1211–1223.
8.
BeckerBFChappellDJacobM. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105(6):687–701.
9.
MulivorAWLipowskyHH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004;286(5):H1672–H1680.
10.
MulivorAWLipowskyHH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol. 2002;283(4):H1282–H1291.
11.
HenryCBDulingBR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol. 2000;279(6):H2815–H2823.
12.
Hofmann-KieferKFKemmingGIChappellDSerum heparan sulfate levels are elevated in endotoxemia. Eur J Med Res. 2009;14(12):526–531.
13.
JacobMChappellDHofmann-KieferKConzenPPeterKRehmM.Determinants of insensible fluid loss: Perspiration, protein shift and endothelial glycocalyx [in German]. Anaesthesist. 2007;56(8):747–758, 760–764.
14.
NelsonABerkestedtISchmidtchenALjunggrenLBodelssonM. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623–627.
15.
MarechalXFavoryRJoulinOEndothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008;29(5):572–576.
16.
HenrichMGrussMWeigandMA. Sepsis-induced degradation of endothelial glycocalix. Scientific World Journal. 2010;10:917–923.
17.
ChappellDHofmann-KieferKJacobMTNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009;104(1):78–89.
18.
OraguiEENadelSKydPLevinM. Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med. 2000;28(8):3002–3008.
19.
RedmanCWSacksGPSargentIL. Preeclampsia: an excessive maternal inflammatory response to pregnancy 1. Am J Obstet Gynecol. 1999;180(2 pt 1):499–506.
20.
MellembakkenJRAukrustPOlafsenMKUelandTHestdalKVidemV. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension. 2002;39(1):155–160.
21.
MellembakkenJRAukrustPHestdalKUelandTAbyholmTVidemV. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension. 2001;38(3):394–398.
22.
HaramKSvendsenEAbildgaardU. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8.
23.
NieuwdorpMvan HaeftenTWGouverneurMCLoss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55(2):480–486.
24.
VinkHConstantinescuAASpaanJA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 2000;101(13):1500–1502.
25.
MartinJNJrRinehartBKMayWLMagannEFTerroneDABlakePG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180(6 pt 1):1373–1384.
26.
O'Hara PaddenM. HELLP Syndrome: recognition and perinatal management. Am Fam Physician. 1999;60(3):829–839.
27.
van Runnard HeimelPJFranxASchobbenAFHuisjesAJDerksJBBruinseHW. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv. 2005;60(1):57–70.
28.
SmithHL. Matching with multiple controls to estimate treatment effects in observational studies. Sociol Methodol. 1997;27:325–353.
RehmMBrueggerDChristFShedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896–1906.
32.
KimJMLeeJAChoISIhmCH. Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study. Korean J Hematol. 2010;45(2):115–119.
33.
AnttonenALeppaSRuotsalainenTAlfthanHMattsonKJoensuuH. Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2003;41(2):171–177.
34.
ParsianHRahimipourANouriMSerum hyaluronic acid and laminin as biomarkers in liver fibrosis. J Gastrointestin Liver Dis. 2010;19(2):169–174.
35.
PuderJJBlumCAMuellerBDeGCDyeLKellerU. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest. 2006;36(1):58–64.
36.
SargentILBorzychowskiAMRedmanCW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006;13(5):680–686.
37.
AlexopoulouANMulthauptHACouchmanJR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007;39(3):505–528.
38.
JokimaaVInkiPKujariHHirvonenOEkholmEAnttilaL. Expression of syndecan-1 in human placenta and decidua. Placenta. 1998;19(2-3):157–163.
39.
KingdomJHuppertzBSeawardGKaufmannP. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 2000;92(1):35–43.
40.
RedmanCWSargentIL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597–602.
41.
KnightMRedmanCWLintonEASargentIL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105(6):632–640.
42.
GoswamiDTannettaDSMageeLAExcess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56–61.
43.
GotteMEchtermeyerF. Syndecan-1 as a regulator of chemokine function. ScientificWorldJournal. 2003;3:1327–1331.
44.
GotteM. Syndecans in inflammation. FASEB J. 2003;17(6):575–591.
45.
JokimaaVIKujariHPEkholmEMInkiPLAnttilaL. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol. 2000;183(6):1495–1498.
46.
SimonACLevensonJFlaudP. Pulsatile flow and oscillating wall shear stress in the brachial artery of normotensive and hypertensive subjects. Cardiovasc Res. 1990;24(2):129–136.
47.
SimonACLevensonJ. Abnormal wall shear conditions in the brachial artery of hypertensive patients. J Hypertens. 1990;8(2):109–114.
48.
BrueggerDJacobMRehmMAtrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol. 2005;289(5):H1993–H1999.
49.
BorghiCCiceroAFDegliEDHemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy. Intern Emerg Med. 2011;6(3):227–234.
50.
KupfermincMJPeacemanAMWigtonTRTamuraRKRehnbergKASocolML. Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol. 1994;171(4):976–979.
51.
ConradKPMilesTMBenyoDF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40(2):102–111.
52.
VinceGSStarkeyPMAustgulenRKwiatkowskiDRedmanCW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol. 1995;102(1):20–25.
53.
VisserWBeckmannIBremerHALimHLWallenburgHC. Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol. 1994;101(12):1081–1082.
54.
SchipperEJBolteACSchalkwijkCGVan GeijnHPDekkerGA. TNF-receptor levels in preeclampsia—results of a longitudinal study in high-risk women. J Matern Fetal Neonatal Med. 2005;18(5):283–287.
55.
van Runnard HeimelPJKavelaarsAHeijnenCJHELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy. 2008;27(3):253–265.
56.
SibaiBRomeroRKlebanoffMAMaternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol. 2009;200(6):630.e1–e8.
57.
FantuzziGDemitriMTGhezziP. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin Exp Immunol. 1994;96(1):166–169.
58.
ReikerasOHelleAKrohnCDBroxJI. Effects of high-dose corticosteroids on post-traumatic inflammatory mediators. Inflamm Res. 2009;58(12):891–897.
59.
ManSFXuekuiZVesseyRThe effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Ther Adv Respir Dis. 2009;3(2):73–80.
60.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.
